Roger Auth
Impact in
-
- Microbial Inactivation Methods
-
- Vibrio bacteria research studies
Papers in
-
- Cystic Fibrosis Research Advances 4
- Pulmonary Hypertension Research and Treatments 1
-
- Bacillus and Francisella bacterial research 4
- Co-authors
- David M. Frucht (4 shared papers)Tao Xie (3 shared papers)Chen Sun (3 shared papers)Hui Fang (3 shared papers)Philip Snoy (2 shared papers)James R. Klinger (1 shared paper)Robert J. Owen (1 shared paper)Lixin Xu (1 shared paper)
- Journals
- PLoS ONE (2 papers)Toxins (1 paper)Journal of Primary Care & Community Health (1 paper)The Journal of Immunology (1 paper)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United States
In The Last Decade
Roger Auth
7 papers receiving 66 citations
Peers
Comparison fields: 5 of 32
- Biotechnology 27
- Endocrinology 6
- Virology 5
- Infectious Diseases 17
- Genetics 21
Countries citing papers authored by Roger Auth
This map shows the geographic impact of Roger Auth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Auth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Auth more than expected).
Fields of papers citing papers by Roger Auth
This network shows the impact of papers produced by Roger Auth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Auth. The network helps show where Roger Auth may publish in the future.
Co-authors
The 15 scholars most cited alongside Roger Auth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 17 | |
| 2 | 2011 | 17 | |
| 3 | 2013 | 12 | |
| 4 | 2010 | 11 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 6 | |
| 7 | 2025 | 1 | |
| 8 | Perceptions and Use of E-cigarettes among Young Adults with Cystic Fibrosis: An Observational Study. | 2023 | 1 |
| 9 | 2020 | 0 | |
| 10 | 2021 | 0 |
About Roger Auth
Roger Auth is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Biotechnology, Genetics and Infectious Diseases, having authored 10 papers that have together received 72 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (4 papers), Bacillus and Francisella bacterial research (4 papers), Microbial Inactivation Methods (3 papers), Yersinia bacterium, plague, ectoparasites research (2 papers), Viral gastroenteritis research and epidemiology (1 paper), Poxvirus research and outbreaks (1 paper), Geriatric Care and Nursing Homes (1 paper) and Pulmonary Hypertension Research and Treatments (1 paper). The work is most often cited by research in Biotechnology (27 citations), Endocrinology (6 citations), Virology (5 citations), Infectious Diseases (17 citations) and Genetics (21 citations). Roger Auth has collaborated with scholars based in United States. Frequent co-authors include David M. Frucht, Tao Xie, Chen Sun, Hui Fang, Philip Snoy, James R. Klinger, Robert J. Owen, Lixin Xu, Debasree Banerjee and Weiming Ouyang. Their work appears in journals such as PLoS ONE, Toxins, Journal of Primary Care & Community Health, The Journal of Immunology and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.